At Mammotome, we are committed to providing best-in-class technology to help clinicians accurately diagnose breast cancer. Never forgetting that at the heart of each breast cancer diagnosis is the patient. We believe that a patient’s diagnosis begins with the right tissue. Our easy-to-use and consistently reliable offerings help improve workflow efficiency and diagnostic confidence. Our extensive product portfolio includes Mammotome breast biopsy devices, specimen radiograph system and tissue markers; distribution of Kubtec’s specimen radiograph systems; the Neoprobe gamma detection system; as well as distribution of the Sentimag platform including the Magseed marker for magnetic lesion localization and the Magtrace liquid marker for radiation-free sentinel lymph node biopsy. For more information, visit mammotome.com and follow Mammotome on social media (Facebook, LinkedIn, Twitter).